Growth Metrics

Prestige Consumer Healthcare (PBH) Non-Current Deferred Tax Liability (2016 - 2025)

Prestige Consumer Healthcare has reported Non-Current Deferred Tax Liability over the past 15 years, most recently at $449.3 million for Q4 2025.

  • Quarterly results put Non-Current Deferred Tax Liability at $449.3 million for Q4 2025, up 8.72% from a year ago — trailing twelve months through Dec 2025 was $449.3 million (up 8.72% YoY), and the annual figure for FY2025 was $419.6 million, up 3.96%.
  • Non-Current Deferred Tax Liability for Q4 2025 was $449.3 million at Prestige Consumer Healthcare, up from $444.9 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for PBH hit a ceiling of $484.8 million in Q1 2022 and a floor of $384.0 million in Q2 2023.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $433.2 million (2021), compared with a mean of $429.9 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: increased 16.19% in 2021 and later dropped 13.24% in 2023.
  • Prestige Consumer Healthcare's Non-Current Deferred Tax Liability stood at $444.8 million in 2021, then grew by 2.48% to $455.8 million in 2022, then dropped by 12.87% to $397.1 million in 2023, then grew by 4.06% to $413.3 million in 2024, then increased by 8.72% to $449.3 million in 2025.
  • The last three reported values for Non-Current Deferred Tax Liability were $449.3 million (Q4 2025), $444.9 million (Q3 2025), and $426.9 million (Q2 2025) per Business Quant data.